COMP <GO>
GRML vs CSBR // OPERATING MARGIN
Greenland Mines Ltd. (NASDAQ) VS. Champions Oncology Inc. (NASDAQ) • 15-METRIC TALLY: GRML 1
— CSBR 3
■ METRIC PARITY
LAST: $4.58 (-10.89%) • MKT CAP: $70.3M
operating-margins
—
LAST: $4.81 (0.00%) • MKT CAP: $66.9M
operating-margins
-1.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GRML VS. CSBR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GRML | CSBR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 48.00% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -26.90% | -8.10 | CSBR | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -8.37% | -7.52% | -0.85 | CSBR | /fcf-yield <GO> |
| Operating Margin ACTIVE | — | -1.90% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | 0.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 4.40% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 2/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.0 | 46.7 | -7.75 | CSBR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $70.3M | $66.9M | $3.4M | GRML | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GRML REV | CSBR REV | GRML GROSS % | CSBR GROSS % | GRML FCF | CSBR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $59.4M | — | 48.0% | -$5.9M | -$5.0M |
| FY 2024 | $0 | $56.9M | — | 50.1% | -$2.9M | $7.0M |
| FY 2023 | $0 | $50.2M | — | — | -$446.9K | -$6.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GRML // BETA —
CSBR // BETA —